RCAP
GILD icon

Resolute Capital Asset Partners’s Gilead Sciences GILD Stock Holding History

Resolute Capital Asset Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,000
Closed -$4.48M – 51
2025
Q1 		$4.48M Buy
+40,000
New +$4.13M 2.52% 11
2024
Q3 		– Sell
-55,000
Closed -$3.77M – 45
2024
Q2 		$3.77M Buy
+55,000
New +$3.67M 2.17% 16

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Resolute Capital Asset Partners's GILD Position: Q2 2025 in Review

Resolute Capital Asset Partners sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 40,000 shares — an estimated $4.48M sold.

Resolute Capital Asset Partners first reported a position in GILD in Q2 2024 and held it in 2 quarters. The position peaked at $4.48M in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Resolute Capital Asset Partners reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Resolute Capital Asset Partners sold 40,000 Gilead Sciences shares in Q2 2025, an estimated $4.48M.
  • Resolute Capital Asset Partners first reported a position in Gilead Sciences in Q2 2024 and held it in 2 quarters.
  • Resolute Capital Asset Partners's Gilead Sciences position peaked at $4.48M in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Resolute Capital Asset Partners's 13F filing for Q2 2025, filed 14 Aug 2025.